Sign in
A Phase 1, Multicenter, Prospective, Open-Label, Dose Escalation Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), in Subjects With Wet AMD
Vrinda S. Hershberger, MD, PhD
On Demand Cases, Courses, and Papers
2021
Wet AMD 4 Symposium
Annual Meeting Talks
2020
Retinal Biomarkers of Alzheimer's Disease with Drs. Cecilia Lee and Rajendra Apte
Keyvan Koushan, MD, FRCSC
Rajendra S. Apte, MD, PhD
Cecilia S Lee, MD
Member Podcasts
Category: Imaging – Digital-Fluorescein angiography